Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A TheraSphere® Advanced Dosimetry Retrospective Global Study Evaluation in Hepatocellular Carcinoma Treatment

NCT03295006 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT03295006
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03295006 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A TheraSphere® Advanced Dosimetry Retrospective Global Study Evaluation in Hepatocellular Carcinoma Treatment
Lead sponsor
Boston Scientific Corporation
Phase
Observational
Overall status
Completed
Start date
October 31, 2016
Completion date
December 1, 2020
Enrollment
209 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma